Page 5 - Anjali Singh

Dr Reddy's Labs Q1FY27 results: Net profit plunges 69% to ₹443 crore

The drugmaker attributed the sharp earnings decline to a one-time semaglutide provision and the end of its lenalidomide agreement, while retaining its FY27 guidance

TVS Motor sees international biz maintaining growth momentum in FY27

Chairman Sudarshan Venu says overseas operations now contribute over a quarter of revenue as the company expands across Africa, Latin America, Asia and Europe

TVS Motor net profit zooms 67% to ₹1,019.4 crore, revenues up 33.5%

Revenue rose 34 per cent as TVS Motor posted record quarterly sales, with management expecting double-digit industry growth to continue on strong exports and EV demand

Takeda gets DCGI approval for QDENGA, India's first dengue vaccine

The vaccine has been approved for individuals aged 4-60 years and can be administered without prior dengue screening, marking India's first vaccine-based strategy against the disease

Emcure broadens Poviztra's use for MASH after CDSCO nod for semaglutide

The drugmaker will market Poviztra for treating MASH after CDSCO approved the new indication for innovator semaglutide, expanding the medicine's approved uses in India

Divi's Labs MD's payout tops ₹100 cr on commissions, leads industry peers

Divi's Laboratories MD Murali K Divi topped India's pharma executive pay chart in FY26 with ₹100.26 crore, driven almost entirely by profit-linked commission

Smart cars' new crash test: Cybersecurity and customer data privacy

Transparency over customer data is becoming a core competitive advantage for brands

Strong H1 dispatches may propel passenger vehicles to record 2026

Robust utility vehicle demand, GST 2.0-led momentum and lower financing costs keep passenger vehicle dispatches strong, with industry expecting record sales in calendar 2026

Ceat Q1 profit plunges 96% on forex losses, higher raw material costs

RPG Group-owned tyre maker reports a sharp fall in Q1 profit due to forex losses and rising input costs, though revenue rose 22.4 per cent on healthy demand across segments

Mahindra's Chakan plant crosses 3 million vehicle production milestone

The BE 6 electric SUV marked the milestone as Mahindra's Chakan plant produced its latest one million vehicles in 27 months, compared with 107 months for the first million

Auto industry posts record Q1 sales; festive demand seen lifting growth

India's automobile industry recorded its strongest-ever first quarter, with record sales across key segments, while SIAM expects festive demand and easier financing to sustain momentum

Cadila Pharma says no curbs on Aciloc products, affirms compliance

Cadila Pharmaceuticals said Aciloc 150+ and Aciloc 300+ remain available without any restrictions on manufacture or sale, while reaffirming compliance with regulatory requirements

Sun Pharma gets South Africa approval for generic semaglutide, launch soon

Sun Pharma has secured South Africa's approval for its generic semaglutide injection and plans to launch the once-weekly diabetes treatment in the coming days

Biocon shares gain 6.5% after Viatris sells its stake in a block deal

Biocon shares climbed 6.5 per cent after reports of Viatris unit Mylan's planned stake sale, with analysts saying the move is a financial decision that removes a long-standing overhang

Auto deal activity falls to 3-year low; capital flows to EV, mobility firms

India's automotive sector recorded $717 million worth of deals in the April-June quarter, with investors favouring fewer but larger transactions in EVs, mobility and automotive technology

PE pivots to MedTech as hospital valuations soar; diagnostics gains

Private equity investors are diversifying into MedTech and diagnostics as rising hospital valuations temper deal appetite, even as India's healthcare sector continues to attract strong capital inflows

FADA says not a single E20-related complaint reported by dealers

FADA says its nationwide dealer network has not reported a single documented E20-related complaint and has launched an awareness drive to address customer concerns

Nissan bets on exports, targets fourfold growth in India sales by FY28

The Japanese automaker aims to sell 100,000 vehicles in India and export another 100,000 annually by FY28, with the new Tekton SUV expected to drive growth

Weak rupee weighs on BMW India margins; further price hikes on the cards

BMW Group India said every Re 1 depreciation in the rupee against the euro trims its profit margin by about 1 per cent, prompting the company to consider further price increases

Tata Motors PV charts 10-fold growth plan by FY31, targets 20% market share

Tata Motors Passenger Vehicles aims to sell more than 1.2 million vehicles annually by FY31, with EVs contributing over 30 per cent of volumes and EBITDA margins in double digits